These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25449039)

  • 1. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection.
    Randhawa PK; Jaggi AS
    Eur J Pharmacol; 2015 Jan; 746():180-5. PubMed ID: 25449039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P.
    Ren JY; Song JX; Lu MY; Chen H
    Regul Pept; 2011 Aug; 169(1-3):49-57. PubMed ID: 21554904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV1 activation is involved in the cardioprotection of remote limb ischemic postconditioning in ischemia-reperfusion injury rats.
    Gao Y; Song J; Chen H; Cao C; Lee C
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1034-9. PubMed ID: 26079883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bradykinin in ischemic conditioning-induced tissue protection: Evidences and possible mechanisms.
    Sharma R; Randhawa PK; Singh N; Jaggi AS
    Eur J Pharmacol; 2015 Dec; 768():58-70. PubMed ID: 26499976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial ischemia/reperfusion injury: potential of TRPV1 agonists as cardioprotective agents.
    Vemula P; Gautam B; Abela GS; Wang DH
    Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):71-8. PubMed ID: 24304232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthetic propofol blunts remote preconditioning of trauma-induced cardioprotection via the TRPV1 receptor.
    Yu J; Chen K; Wu L; Liu X; Lu Y
    Biomed Pharmacother; 2019 Oct; 118():109308. PubMed ID: 31401396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of ischemic conditioning: translation into patient outcomes.
    Brooks MJ; Andrews DT
    Future Cardiol; 2013 Jul; 9(4):549-68. PubMed ID: 23834695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing the diabetic heart: does myocardial preconditioning work?
    Balakumar P; Sharma NK
    Cell Signal; 2012 Jan; 24(1):53-9. PubMed ID: 21945408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Potential Involvement of TRPV
    Randhawa PK; Jaggi AS
    J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):38-45. PubMed ID: 28466657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenously generated arachidonate-derived ligands for TRPV1 induce cardiac protection in sepsis.
    Chen J; Hamers AJP; Finsterbusch M; Massimo G; Zafar M; Corder R; Colas RA; Dalli J; Thiemermann C; Ahluwalia A
    FASEB J; 2018 Jul; 32(7):3816-3831. PubMed ID: 29465314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion.
    Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM
    J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes.
    Bian JS; Yong QC; Pan TT; Feng ZN; Ali MY; Zhou S; Moore PK
    J Pharmacol Exp Ther; 2006 Feb; 316(2):670-8. PubMed ID: 16204473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice.
    Wang L; Wang DH
    Circulation; 2005 Dec; 112(23):3617-23. PubMed ID: 16314376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of kappa opioid receptors in cardioprotection against ischemia: the signaling mechanisms.
    Wong TM; Wu S
    Sheng Li Xue Bao; 2003 Apr; 55(2):115-20. PubMed ID: 12715097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning.
    Gerczuk PZ; Kloner RA
    Hosp Pract (1995); 2011 Aug; 39(3):35-43. PubMed ID: 21881390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPV
    Randhawa PK; Jaggi AS
    Int J Cardiol; 2017 Feb; 228():103-113. PubMed ID: 27863349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective signalling: Past, present and future.
    Jovanović A
    Eur J Pharmacol; 2018 Aug; 833():314-319. PubMed ID: 29935170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.